JP

Josel Perrika Selvakumar

Active Director Director DIN 10268266
DIN 10268266 First appointment Aug 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Josel Perrika Selvakumar

Data last updated:

Josel Perrika Selvakumar is a Director at Dr.Jora Naturopathy Private Limited (since 2023). The company operates in Paper.

DIN 10268266
Primary Designation Director
Industry Paper
First Appointment 04 Aug 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dr.Jora Naturopathy Private Limited U21009MH2023PTC408128
Director04 Aug 20232023Active

Board colleagues of Josel Perrika Selvakumar

NameDINCompanyDesignation
Joramaysepa Selvakumar10268267Dr.Jora Naturopathy Private LimitedDirector

Directorship timeline

Open interactive timeline →
Dr.Jora Naturopathy Private Limited
Premium access

Shareholding and investment profile for Josel Perrika Selvakumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Josel Perrika Selvakumar

Josel Perrika Selvakumar currently holds 1 directorship: Dr.Jora Naturopathy Private Limited (Director, since 04 Aug 2023).

Josel Perrika Selvakumar was first appointed on 04 Aug 2023 as Director at Dr.Jora Naturopathy Private Limited.

The current boards of Josel Perrika Selvakumar's companies include Joramaysepa Selvakumar (Dr.Jora Naturopathy Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available